ArticleNeuro-oncology advances

Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial data.

Daniela A Bota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.